we need the right direction (and new ceo) asap, page-9

My questions for tommorrow.

Why is GSK no longer reporting Relenza in its quarterlys

How can BTA help me in regards to my super fund force selling my shares.

What are the total liabilities of NABI. $ amount

BTA must now concentrate fully on PR of its pipeline. They must communicate the story better.

Have BTA got verbal or written approval for deal from key NABI holders.
Ditto BTA holders.

When will the ROW licensing deal with DS be finalized.

What is the next stage for Vapan. Licence or BTA funded stage 3 etc

RSV update

anitinfectives update.

Any more.